Draft:Flow Neuroscience

Flow Neuroscience is a medical device company based in Malmö, Sweden and London, UK. The company develops and sells Flow, a noninvasive brain stimulation device to treat depression.

Flow Neuroscience was founded in 2016 by computational neuroscientist Erik Rehn and psychologist Daniel Månsson.

Flow - Depression treatment
In 2019 Flow Neuroscience received regulatory approval in the EU and UK for the treatment of major depressive disorder. The product, called Flow, is a noninvasive brain stimulation headset which is used by the patients themselves at home. The headset delivers weak direct electrical current via electrodes to restore activity in the left frontal lobe. In 2023, the UK NICE reviewed the evidence for Flow and concluded that the device is beneficial for those who do not improve with existing interventions or have side-effects from medication, but that it can also be used as a first-line treatment.